Mastrapasqua Asset Management Inc Amgen Inc Transaction History

Mastrapasqua Asset Management Inc

$853 Million
Q3 2023

A detailed history of Mastrapasqua Asset Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Mastrapasqua Asset Management Inc holds 56,828 shares of AMGN stock, worth $15 Million. This represents 1.79% of its overall portfolio holdings.

Number of Shares

56,828

Previous 57,225 0.69%

Holding current value

$15 Million

Previous $12.7 Million 20.21%

% of portfolio

1.79%

Previous 1.43%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 25, 2023	SELL	$218.65 - $271.46 $86,804 - $107,769	-397 Reduced 0.69%	56,828 $15.3 Million
Q2 2023 Aug 02, 2023	BUY	$214.27 - $253.37 $229,054 - $270,852	1,069 Added 1.9%	57,225 $12.7 Million
Q1 2023 Apr 27, 2023	SELL	$225.79 - $275.2 $113,120 - $137,875	-501 Reduced 0.88%	56,156 $13.6 Million
Q4 2022 Feb 01, 2023	SELL	$229.03 - $291.01 $125,737 - $159,764	-549 Reduced 0.96%	56,657 $14.9 Million
Q3 2022 Oct 27, 2022	BUY	$224.46 - $253.15 $276,085 - $311,374	1,230 Added 2.2%	57,206 $12.9 Million
Q2 2022 Jul 26, 2022	SELL	$230.71 - $256.74 $140,963 - $156,868	-611 Reduced 1.08%	55,976 $13.6 Million
Q1 2022 Apr 21, 2022	SELL	$219.27 - $242.57 $759,770 - $840,505	-3,465 Reduced 5.77%	56,587 $13.7 Million
Q4 2021 Jan 21, 2022	BUY	$198.88 - $227.6 $64,238 - $73,514	323 Added 0.54%	60,052 $13.5 Million
Q3 2021 Nov 01, 2021	SELL	$212.27 - $248.7 $324,773 - $380,511	-1,530 Reduced 2.5%	59,729 $12.7 Million
Q2 2021 Aug 06, 2021	BUY	$233.58 - $259.14 $70,074 - $77,742	300 Added 0.49%	61,259 $14.9 Million
Q1 2021 May 03, 2021	BUY	$221.91 - $258.6 $594,940 - $693,306	2,681 Added 4.6%	60,959 $15.2 Million
Q4 2020 Feb 02, 2021	SELL	$216.38 - $257.67 $504,165 - $600,371	-2,330 Reduced 3.84%	58,278 $13.4 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $224,090 - $249,207	955 Added 1.6%	60,608 $15.4 Million
Q2 2020 Jul 29, 2020	SELL	$197.81 - $242.74 $98,905 - $121,370	-500 Reduced 0.83%	59,653 $14.1 Million
Q1 2020 May 08, 2020	BUY	$182.24 - $241.7 $244,930 - $324,844	1,344 Added 2.29%	60,153 $12.2 Million
Q4 2019 Feb 05, 2020	BUY	$189.21 - $243.2 $4,162 - $5,350	22 Added 0.04%	58,809 $14.2 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $98,720 - $118,287	-567 Reduced 0.96%	58,787 $11.4 Million
Q2 2019 Aug 12, 2019	SELL	$166.7 - $195.41 $142,528 - $167,075	-855 Reduced 1.42%	59,354 $10.9 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $2,893 - $3,262	-16 Reduced 0.03%	60,209 $11.4 Million
Q4 2018 Feb 12, 2019	SELL	$178.4 - $208.25 $105,791 - $123,492	-593 Reduced 0.98%	60,225 $11.7 Million
Q3 2018 Nov 15, 2018	BUY	$185.29 - $208.89 $339,080 - $382,268	1,830 Added 3.1%	60,818 $12.6 Million
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $103,117 - $115,822	-621 Reduced 1.04%	58,988 $10.9 Million
Q1 2018 Sep 24, 2018	SELL	$169.43 - $198.0 $28,972 - $33,858	-171 Reduced 0.29%	59,609 $10.2 Million
Q4 2017 Feb 09, 2018	SELL	$168.79 - $188.59 $212,675 - $237,623	-1,260 Reduced 2.06%	59,780 $10.4 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $130,820 - $149,362	782 Added 1.3%	61,040 $11.4 Million
Q2 2017 Aug 07, 2017	BUY	N/A	60,258	60,258 $10.4 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mastrapasqua Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mastrapasqua Asset Management Inc with notifications on news.

Account

Mastrapasqua Asset Management Inc Amgen Inc Transaction History